North America

The Hamilton and Amabel James Center for Artificial Intelligence and Human Health will focus on genomics, modeling and prediction of novel therapies and enhanced imaging. 

Khosla Ventures led the funding round with participation from Dai-ichi Life, SOMPO holdings, Sozo Ventures, Rethink Impact, AME Cloud Partners and Marc Benioff. 

The IB-Stim device adheres behind the patient's ear for up to five days, and may assist with pain reduction for up to three consecutive weeks.

The FDA approval closes a gap with competitors Dexcom and Abbott, as well as setting the company up for entry into the Medicare market.

The sector has undergone major changes in the past few years, and venture capitalists are still keen to dip their toes in.

Wildflower, Omada and Welkin Health have lessons to share about working with large enterprises.

The new platform called Chronically Simple lets patients store test results, diagnostic images and medical records. 

Quil Health's platform delivers episodic care support content through a smartphone app and, if permitted by the patient, their living room television.

UCHealth led the funding with participation from the University of Virginia LVG Venture Fund, Presbyterian Healthcare Services, Inception Health/Froedtert Health, Children’s Hospital Colorado, UnityPoint Health, JAZZ Venture Partners and existing investors.